Ku worked in Chile for more than 20 years as an importer and exporter, but she returned to her home in southern China earlier this year and a large number of cases occurred in South America after the coronovirus epidemic worsened.
There was no official announcement that a series of articles was available in local media – a vaccine in Yivu – but KU believed he needed a shot to leave China and get a job overseas. “If there is one (vaccine), it is more safe to leave the country,” she said.
Yiwu is one of the cities that has been offering experimental coronavirus vaccines to select members of the public in recent weeks despite reportedly undergoing clinical trials. Zhejiang, another city in Zhejiang Province, announced on October 15 that it would sell vaccines to citizens in “urgent” need.
The Jiaxing Center for Disease Control posted in its official WeChat account on October 15, “Citizens in need of immediate vaccination can go to the community hospital for consultation based on community voluntary and informed consent. Approximately $ 60 for a vaccine in Jiaxing According to the statement, two doses are required once.
Globally, there is currently no coronavirus vaccine that has been successfully tested and proven to be safe to use. As of October, four Kovid-19 vaccines designed by Chinese companies were in Phase 3 clinical trials, the final and most important step before regulatory approval for the drug.
When CNN visited the hospital on 19 October, where KU went on 19 October, staff confirmed that in the previous week they were giving experimental coronavirus vaccination to citizens who were urgently required to travel abroad. However, no one who spoke to CNN had taken the vaccine.
The Yivu government has not yet made a public statement on the release of the experimental vaccines. He has been contacted by CNN for comment.
Jiaxing and Yiwu officials have not explicitly stated what constitutes the “immediate” requirement for the experimental vaccine, what evidence is required to show you a shot, or that these cities in Zhejiang, rather than large metolize Why emergency dosing was allowed was in the form of Beijing or Shanghai.
An article by the state’s Tabloid Global Times on Tuesday denied that the Kovid-19 vaccine was publicly available.
However, some regular citizens arriving in Yiwu and Jiaxing by train or plane in hopes of getting their hands on the experimental vaccine have not been stopped.
A rollout of vaccination using experimental drugs is still being announced in other cities of Zhejiang. On Tuesday, the city of Shaoxing said that “emergency vaccination” would be given in the autumn and winter, with the time and date yet to be announced.
Video: Chinese city offers experimental Kovid-19 vaccine (CNN) to some people
Click to enlarge
Since the initial outbreak in December 2019, China has gradually brought its local coronovirus epidemic under control, through a combination of citywide lockdown, mass testing and sophisticated track and trace tools.
Now Beijing is at the forefront of the global effort to find a coronovirus vaccine, with Chinese President Xi Jinping repeatedly urging the country’s scientists to expedite their work. On 20 October, Tian Boguo, an official in the Ministry of Science and Technology, said 60,000 people were injected as part of a drug trial and no serious adverse reactions were reported.
“Currently, China’s vaccine research and development work is generally in a leading position,” he said.
But ahead of approval of any vaccine, the Chinese government is moving forward with a series of vaccinations for those they believe are at risk or in high-profile status.
The apparent push to make the vaccine publicly available with other countries including the United States, where drug manufacturers and regulators have so far taken precautions.
In June, Beijing approved the use of the experimental vaccine by Cancino Biologics in the country’s military.
Three months later, the Chinese government approved the emergency use of the vaccine, also known as Sinoperm, for medical professionals, diplomats from high-risk countries, and employees of a state-owned company working abroad.
A large number of people have already been vaccinated. In early October, Yang Xiaoming, president of China’s National Biotech Group, who has just had two vaccines in three-phase trials, said his drug was given to about 350,000 people in emergency doses authorized by the Chinese government so far. These vaccinations are not part of the ongoing drug trial.
A virologist at Hong Kong University, Drs. Jin Dong-yan told CNN that it was “risky” to pursue it with vaccination before the drug was fully tested and cleared.
“There are many examples in the history of the development of the vaccine that even if the vaccine has passed stage 3, there can still be problems,” Jin said. None of the experimental vaccines has passed Phase 3 yet.
The Yiwu and Jiaxing vaccine programs are not the first time an unpublished coronavirus vaccine has been offered to select members of the public in China.. In early October, an offer was delivered online online by Sinopharm for a free vaccine for foreign students to study Chinese.
However, after being advertised for a few days, offers were pulled and it is unclear whether any vaccines were actually provided.
Mino Guo was one of the students registering for the vaccine while living in her hometown of Guangdong in the south of the country, as she was keen to return to the United States in November to pursue her studies.
“America’s situation is a little bit serious. I’m not too worried about it, but my family and friends around me worry about my life. So that’s why I feel that to make my family feel, getting a vaccine Necessary. Safe, “he said.
Guo said that she was a little worried about what effect the vaccine might have on her, but she never got it in the end.
So far no special treatment is being offered in China to people who have received the experimental coronavirus vaccine, such as permission to travel without a mask.